A new UCLA Health study finds a clue that could help reduce serious neurological side effects associated with CAR T-cell therapy known as immune effec...
An 8-year study of nearly 1300 low-income adolescents in Los Angeles found that students who attended high performing charter high schools were much l...
The new medication targets a protein called apolipoprotein C-III. By neutralizing this protein, it effectively speeds up the breakdown of triglycerides.
Melissa Spencer, professor of neurology and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA has re...
For men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in fewer toxicities and be...